Pure Global

Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen Concentrators at Home - Trial NCT05730088

Access comprehensive clinical trial information for NCT05730088 through Pure Global AI's free database. This phase not specified trial is sponsored by Necmettin Erbakan University and is currently Not yet recruiting. The study focuses on Pulmonary Disease, Chronic Obstructive. Target enrollment is 74 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT05730088
Not yet recruiting
other
Trial Details
ClinicalTrials.gov โ€ข NCT05730088
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Reducing the Number of Hospital Admissions With Multiple Nursing Interventions in COPD Patients Using Oxygen Concentrators at Home
The Effect of Post-Discharge Multiple Nursing Interventions on the Number of Hospital Admissions, Dyspnea Level, and Quality of Life in COPD Patients Receiving Home Oxygen Therapy: A Randomized Controlled Study

Study Focus

health education

Interventional

other

Sponsor & Location

Necmettin Erbakan University

Timeline & Enrollment

N/A

Feb 15, 2023

Aug 15, 2023

74 participants

Primary Outcome

number of hospital admissions,number of hospital admissions,number of hospital admissions

Summary

Chronic obstructive pulmonary disease (COPD) is a progressive lung disease characterized by
 persistent airflow obstruction and chronic respiratory symptoms or alpha-1-antitrypsin
 deficiency in response to inhaled cigarette smoke or other irritants. The excessive morbidity
 and mortality associated with COPD acute exacerbations represent a significant public health
 problem that places a high burden on patients, their families and society. In frequent and
 severe exacerbations, patients may experience a decrease in quality of life, depression, and
 even death up to one year after hospitalization. Costs associated with COPD are more than
 $15.5 billion, and hospitalizations and repeated hospital admissions related to acute
 exacerbations alone account for 70% of all costs. For these reasons, efforts to reduce
 hospital admissions and hospitalizations associated with recurrent exacerbations are
 imperative to improve patient's quality of life and reduce the societal burden.

ICD-10 Classifications

Chronic obstructive pulmonary disease, unspecified
Other chronic obstructive pulmonary disease
Other specified chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
Chronic obstructive pulmonary disease with acute lower respiratory infection

Data Source

ClinicalTrials.gov

NCT05730088

Non-Device Trial